Use the journals feature with a free QxMD account.
Use Read by QxMD to access full text via your institution or open access sources.
Read also provides personalized recommendations to keep you up to date in your field.
Existing User
Sign InNew to Read
Sign Up#1
JOURNAL ARTICLE
En bloc endoscopic submucosal dissection of a large laterally spreading tumor involving the papilla.
Shuhan Yu, Yonggang Ding, Qide Zhang
No abstract text is available yet for this article.
April 17, 2024: Clinical Gastroenterology and Hepatology
#2
LETTER
Sivesh K Kamarajah, Graeme MacLennan, Sanjay Pandanaboyana
No abstract text is available yet for this article.
April 15, 2024: Clinical Gastroenterology and Hepatology
#3
JOURNAL ARTICLE
Sarah Enslin, Vivek Kaul
No abstract text is available yet for this article.
April 13, 2024: Clinical Gastroenterology and Hepatology
#4
JOURNAL ARTICLE
Marisa G Stahl, Zhaoxing Pan, Monique Germone, Sadie Nagle, Pooja Mehta, Mary Shull, Isabel Griffith, Brianne Shuler, Edward Hoffenberg, Iman Taki, Cristy Geno-Rasmussen, Marian J Rewers, Jill M Norris, Edwin Liu
BACKGROUND: Celiac disease (CD) mass screening remains controversial in part because of a paucity of data to support its benefit. The Autoimmunity Screening for Kids (ASK) study is a mass screening study for pediatric CD and type 1 diabetes in Colorado. METHODS: This study prospectively follows children ages 1-17 years who screened positive for tissue transglutaminase IgA autoantibodies (tTGA) in the ASK study subsequently referred for diagnostic evaluation. Children diagnosed with CD by biopsy or serologic criteria were included in this study...
April 12, 2024: Clinical Gastroenterology and Hepatology
#5
JOURNAL ARTICLE
Susumu Hijioka, Daiki Yamashige, Minoru Esaki, Goro Honda, Ryota Higuchi, Toshihiko Masui, Yasuhiro Shimizu, Masayuki Ohtsuka, Yusuke Kumamoto, Akio Katanuma, Naoto Gotohda, Hirofumi Akita, Michiaki Unno, Itaru Endo, Yukihiro Yokoyama, Suguru Yamada, Ippei Matsumoto, Takao Ohtsuka, Satoshi Hirano, Hiroaki Yasuda, Manabu Kawai, Taku Aoki, Masafumi Nakamura, Daisuke Hashimoto, Toshiki Rikiyama, Akihiko Horiguchi, Tsutomu Fujii, Shugo Mizuno, Keiji Hanada, Masaji Tani, Takashi Hatori, Tetsuhide Ito, Masataka Okuno, Shingo Kagawa, Hiroshi Tajima, Tatsuya Ishii, Motokazu Sugimoto, Shunsuke Onoe, Hideki Takami, Ryoji Takada, Takayuki Miura, Yusuke Kurita, Keiko Kamei, Yuko Mataki, Kazuichi Okazaki, Yoshifumi Takeyama, Hiroki Yamaue, Sohei Satoi
BACKGROUND & AIMS: Despite previously reported treatment strategies for nonfunctioning small (≤20 mm) pancreatic neuroendocrine neoplasms (pNENs), uncertainties persist. We aimed to evaluate the surgically resected cases nonfunctioning small pNENs (NF-spNENs) in a large Japanese cohort to elucidate an optimal treatment strategy for NF-spNENs. METHODS: In this Japanese multicenter study, data were retrospectively collected from patients who underwent pancreatectomy between January 1996 and December 2019, were pathologically diagnosed with pNEN, and were treated according to the WHO 2019 classification...
April 12, 2024: Clinical Gastroenterology and Hepatology
#6
JOURNAL ARTICLE
Yuya Seko, Kanji Yamaguchi, Toshihide Shima, Michihiro Iwaki, Hirokazu Takahashi, Miwa Kawanaka, Saiyu Tanaka, Yasuhide Mitsumoto, Masato Yoneda, Atsushi Nakajima, Takeshi Okanoue, Yoshito Itoh
BACKGROUND & AIMS: PNPLA3 rs738409, TM6SF2 rs58542926, and HSD17B13 rs72613567 have been associated with an increased risk of liver-related events (LRE) in patients with metabolic dysfunction-associated steatotic liver disease (MASLD). In this study, we investigated the combined effects of these variants on LRE. METHODS: The longitudinal multicenter cohort study enrolled 1178 patients with biopsy-proven MASLD. We calculated the genetic risk of hepatic fibrosis and LRE according to the impact of these variants...
April 9, 2024: Clinical Gastroenterology and Hepatology
#7
REVIEW
Jesús Rivera-Esteban, Sergio Muñoz-Martínez, Mónica Higuera, Elena Sena, María Bermúdez-Ramos, Juan Bañares, María Martínez-Gomez, M Serra Cusidó, Alba Jiménez-Masip, Sven M Francque, Frank Tacke, Beatriz Minguez, Juan M Pericàs
Hepatocellular carcinoma (HCC) typically develops as consequence of liver cirrhosis, but HCC epidemiology has evolved drastically in recent years. Metabolic dysfunction-associated steatotic liver disease (MASLD), including metabolic dysfunction-associated steatohepatitis (MASH), has emerged as the most common chronic liver disease worldwide and a leading cause of HCC. A substantial proportion of MASLD-associated HCC (MASLD-HCC) can also develop in patients without cirrhosis. The specific pathways that trigger carcinogenesis in this context are not completely elucidated, and recommendations for HCC surveillance in MASLD patients are challenging...
April 9, 2024: Clinical Gastroenterology and Hepatology
#8
JOURNAL ARTICLE
Nikhil R Thiruvengadam, Monica Saumoy, Douglas E Schaubel, Peter B Cotton, B Joseph Elmunzer, Martin L Freeman, Shyam Varadarajulu, Michael L Kochman, Gregory A Coté
BACKGROUND & AIMS: Greater availability of less invasive biliary imaging to rule out choledocholithiasis should reduce the need for diagnostic endoscopic retrograde cholangiopancreatography (ERCP) in patients who have a remote history of cholecystectomy. The primary aims were to determine the incidence, characteristics, and outcomes of individuals who undergo first-time ERCP > 1 year after cholecystectomy (late-ERCP). METHODS: Data from a commercial insurance claim database (Optum Clinformatics) identified 583,712 adults who underwent cholecystectomy, 4,274 of whom underwent late-ERCP, defined as first-time ERCP for nonmalignant indications > 1 year after cholecystectomy...
April 8, 2024: Clinical Gastroenterology and Hepatology
#9
JOURNAL ARTICLE
Angela Z Xue, Chelsea Anderson, Cary C Cotton, Charles E Gaber, Cynthia Feltner, Evan Dellon
BACKGROUND AND AIMS: Esophageal strictures are a leading cause of dysphagia, but data regarding the epidemiology of esophageal strictures are limited. This study aimed to investigate the prevalence, healthcare utilization, and financial burden of esophageal strictures in the United States. METHODS: We performed a retrospective cohort study utilizing two large national insurance claims databases (MarketScan and Medicare). Using ICD-9 and -10 diagnostic codes, annual prevalence was calculated for both cohorts overall, as well as stratified by age and sex strata...
April 6, 2024: Clinical Gastroenterology and Hepatology
#10
JOURNAL ARTICLE
Sung Hyun Cho, Dong-Wan Seo, Dongwook Oh, Tae Jun Song, Sung Koo Lee
BACKGROUND AND AIMS: Endoscopic ultrasound-guided pancreatic cyst ablation (EUS-PCA) is performed as an alternative to surgical resection in selected patients with pancreatic cystic tumors (PCTs). However, no studies have been conducted to compare outcomes between EUS-PCA and surgery for PCTs. METHODS: We reviewed a PCT database to identify patients with unilocular or oligolocular PCTs who underwent EUS-PCA or surgery between January 2004 and July 2019. We performed 1:1 propensity score matching based on potential confounding factors...
April 6, 2024: Clinical Gastroenterology and Hepatology
#11
JOURNAL ARTICLE
Noah C Peeri, Peter S Liang, Kelli O'Connell, David A Katzka, Elizabeth D Kantor, Mengmeng Du
No abstract text is available yet for this article.
April 6, 2024: Clinical Gastroenterology and Hepatology
#12
EDITORIAL
Juho Asteljoki, Panu K Luukkonen
No abstract text is available yet for this article.
April 6, 2024: Clinical Gastroenterology and Hepatology
#13
LETTER
Maria Pilar Ballester, Juan Antonio Carbonell-Asins, Thomas Reiberger
No abstract text is available yet for this article.
April 6, 2024: Clinical Gastroenterology and Hepatology
#14
LETTER
Kasper A Overbeek, Djuna L Cahen, Marco J Bruno
No abstract text is available yet for this article.
April 5, 2024: Clinical Gastroenterology and Hepatology
#15
LETTER
William L Hasler
No abstract text is available yet for this article.
April 5, 2024: Clinical Gastroenterology and Hepatology
#16
LETTER
Anthony Kerbage, Jean-Paul Achkar, Carol Rouphael
No abstract text is available yet for this article.
April 5, 2024: Clinical Gastroenterology and Hepatology
#17
JOURNAL ARTICLE
Ani Kardashian, Audrey Lloyd, Eduardo Vilar-Gomez, Susanna Naggie, Mark S Sulkowski, Tinsay Woreta, Jordan E Lake, Holly Crandall, Rohit Loomba, Laura A Wilson, Richard K Sterling, Sonya Heath, Samer Gawrieh, Naga P Chalasani, Jennifer C Price
BACKGROUND & AIMS: Food insecurity (FI) is a risk factor for nonalcoholic fatty liver disease (NAFLD) and advanced fibrosis in the general population, but its impact on liver disease in people with HIV (PWH) is unknown. METHODS: We examined the association of FI with prevalence of NAFLD and fibrosis in a diverse cohort of PWH. PWH aged ≥18 years on antiretroviral therapy, HIV RNA<200 copies/mL, and without other known liver diseases were screened for NAFLD (CAP≥263 decibels/meter) and advanced fibrosis (LSM≥11 kilopascals) by vibration controlled transient elastography at eight US centers...
April 5, 2024: Clinical Gastroenterology and Hepatology
#18
(no author information available yet)
No abstract text is available yet for this article.
April 3, 2024: Clinical Gastroenterology and Hepatology
#19
LETTER
Qingzhou Kong, Kunping Ju, Yueyue Li
No abstract text is available yet for this article.
April 3, 2024: Clinical Gastroenterology and Hepatology
#20
JOURNAL ARTICLE
S A Firkins, J Yates, N Shukla, R Garg, J Vargo, A Lembo
No abstract text is available yet for this article.
April 2, 2024: Clinical Gastroenterology and Hepatology
Make the most of Read.
Download the mobile app.
Download the mobile app.
Fetching more papers... 
